Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-28 @ 11:20 PM
Study NCT ID:
NCT05993234
Status:
RECRUITING
Last Update Posted:
2025-12-11
First Post:
2023-08-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY)
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'interventionBrowseModule': {'meshes': [{'id': 'C000614160', 'term': 'trastuzumab deruxtecan'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 257}, 'targetDuration': '2 Years', 'patientRegistry': True}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2023-12-05', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-12', 'completionDateStruct': {'date': '2027-09-01', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2025-12-04', 'studyFirstSubmitDate': '2023-08-02', 'studyFirstSubmitQcDate': '2023-08-11', 'lastUpdatePostDateStruct': {'date': '2025-12-11', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2023-08-15', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2026-12-01', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Real-World Time to Next Treatment (rwTTNT1) in Participants With HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma', 'timeFrame': 'Baseline up to approximately 2 years'}], 'secondaryOutcomes': [{'measure': 'Number of Physician Visits and Treatment Changes in Participants With HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma', 'timeFrame': 'Baseline up to approximately 2 years'}, {'measure': 'Number of Physician-reported Safety Events of Interest in Participants With HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma (T-DXd only)', 'timeFrame': 'Baseline up to approximately 2 years'}, {'measure': 'Number of Participants Receiving Prophylactic and Reactive Treatment Management for Physician-reported Safety Events of Interest in Participants With HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma (T-DXd only)', 'timeFrame': 'Baseline up to approximately 2 years'}, {'measure': 'Real-World Time to Permanent Treatment Discontinuation (rwTTD1) in Participants With HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma', 'timeFrame': 'Baseline up to approximately 2 years'}, {'measure': 'European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) Scores in Participants With HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma', 'timeFrame': 'Baseline up to approximately 2 years', 'description': 'The EORTC QLQ-C30 questionnaire is a cancer-specific quality of life instrument applicable to a broad range of cancer patients. The EORTC QLQ-C30 scales and single-item scales range in score from 0 to 100. A higher score for the functioning scales and global health status denotes a better level of functioning (i.e. a better state of the patient), while higher scores on the symptom and single-item scales indicate a higher level of symptoms (i.e. a worse state of the patient).'}, {'measure': 'European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Stomach (EORTC QLQ-STO22) Score in Participants With HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma', 'timeFrame': 'Baseline up to approximately 2 years', 'description': 'The EORTC QLQ-STO22 is a gastric cancer-specific module which has been developed to measure the quality of life in patients with gastric cancer. The gastric cancer specific questions on the EORTC QLQ-STO22 include four single-item subscales (dry mouth, body image, hair loss and problems with taste) and five multi-item subscales (dysphagia, dietary restriction, pain, upper gastroesophageal symptoms and emotional problems). The EORTC QLQ single-item and multi-item scales range in score from 0 to 100. A higher score on the symptom and single-item scales indicate a higher level of symptoms (i.e. a worse state of the patient)'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': True, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['HER2-positive Advanced Gastric Cancer', 'HER2-positive Gastroesophageal Junction Adenocarcinoma', 'Trastuzumab Deruxtecan', 'Conventional therapy', 'ENHERTU®'], 'conditions': ['HER2-positive Advanced Gastric Cancer', 'HER2-positive Gastroesophageal Junction Adenocarcinoma']}, 'descriptionModule': {'briefSummary': 'Trastuzumab deruxtecan (T-DXD) as monotherapy is indicated for the treatment of adult patients with advanced HER2-positive advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma who have received a prior trastuzumab-based regimen.\n\nThis study will assess the effectiveness of T-DXd, patient demographic and clinical characteristics, and treatment patterns in patients with advanced HER2-positive advanced gastric or GEJ adenocarcinoma.', 'detailedDescription': 'This non-interventional study will investigate the effectiveness of T-DXd, the patients demographic and clinical characteristics, treatment patterns including prophylactic medications and interventions for reduction of serious adverse events (SAEs), serious adverse drug reactions (ADRs) and safety event of interest (SEIs), tolerability, and patient survey of T-DXd, in cases with advanced HER2-positive gastric or GEJ adenocarcinoma receiving T-DXd as second line of treatment and beyond treatment option. Patients will be treated according to the proposed indication statement in the Summary of Product Characteristics (SmPC). No investigational drug will be administered in this study.\n\nData on conventional therapy (including platinum-fluoropyrimidine doublet chemotherapy, nivolumab, ramucirumab-paclitaxel, ramucirumab monotherapy, taxane or irinotecan, and pembrolizumab monotherapy) will also be collected in a disease registry part of the study.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Adult patients with advanced HER2-positive gastric or GEJ adenocarcinoma who have received a prior trastuzumab-based regimen in a real-world setting in Europe.', 'healthyVolunteers': False, 'eligibilityCriteria': "Inclusion Criteria:\n\n* Male or female adult patient (age ≥ 18 years) with HER2 + advanced gastric or GEJ adenocarcinoma who have received a prior trastuzumab based regimen\n* Histological or cytological confirmed diagnosis of advanced HER2 positive gastric cancer or GEJ\n* Documented HER2 + status (archival sample or recent sample prior 2L therapy)\n* Decision to newly initiate monotherapy T-DXd or conventional therapies per SMPC according to the physician's choice\n* Written dated and signed Informed Consent (ICF) to participate in the study\n\nExclusion Criteria:\n\n* Patients who at time of data collection for this study are participating in or have participated in an interventional study that remains blinded\n* Pregnancy or breastfeeding\n\nNo specific exclusion criteria are defined, as patients will be treated according to the proposed indication statements in the SmPC."}, 'identificationModule': {'nctId': 'NCT05993234', 'briefTitle': 'A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY)', 'organization': {'class': 'INDUSTRY', 'fullName': 'Daiichi Sankyo'}, 'officialTitle': 'A Prospective Non-interventional Study (NIS) of Trastuzumab DeRuxtecan (T-DXd) for Adult Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction (GEJ) AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen, Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies in a Real-world Setting in Europe (PROSPERITY)', 'orgStudyIdInfo': {'id': 'DS8201-0007-NIS-MA'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'Trastuzumab deruxtecan (T-DXd)', 'description': 'Participants with HER2-positive gastric or gastroesophageal junction adenocarcinoma who will be treated with trastuzumab deruxtecan and part of the enrolled participants will receive conventional therapy. The participants on conventional therapy will be analyzed for exploratory purposes only.', 'interventionNames': ['Drug: Trastuzumab deruxtecan']}], 'interventions': [{'name': 'Trastuzumab deruxtecan', 'type': 'DRUG', 'otherNames': ['T-DXd', 'ENHERTU®'], 'description': 'This is a non-interventional study and medication will be administered according to the SmPC as local standard of care and as part of the routine clinical practice.\n\nT-DXd to be administered according to the SmPC. Conventional therapy (eg. platinum-fluoropyrimidine doublet chemotherapy, nivolumab, ramucirumab-paclitaxel, ramucirumab monotherapy, taxane or irinotecan, and pembrolizumab monotherapy) to be administered according to the SmPC.', 'armGroupLabels': ['Trastuzumab deruxtecan (T-DXd)']}]}, 'contactsLocationsModule': {'locations': [{'zip': '9020', 'city': 'Klagenfurt', 'status': 'RECRUITING', 'country': 'Austria', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'KABEG Klinikum Klagenfurt am Wörthersee - Landeskrankenanstalten LKH', 'geoPoint': {'lat': 46.62472, 'lon': 14.30528}}, {'zip': '4010', 'city': 'Linz', 'status': 'RECRUITING', 'country': 'Austria', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Ordensklinikum Linz GmbH Barmherzige Schwestern', 'geoPoint': {'lat': 48.30639, 'lon': 14.28611}}, {'zip': '3100', 'city': 'Sankt Pölten', 'status': 'RECRUITING', 'country': 'Austria', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Universitätsklinikum St. Pölten - Lilienfeld', 'geoPoint': {'lat': 48.20762, 'lon': 15.63725}}, {'zip': '1090', 'city': 'Vienna', 'status': 'RECRUITING', 'country': 'Austria', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Medizinische Universität Wien', 'geoPoint': {'lat': 48.20849, 'lon': 16.37208}}, {'zip': '1130', 'city': 'Vienna', 'status': 'WITHDRAWN', 'country': 'Austria', 'facility': 'St. Josef Krankenhaus GmbH Ein Unternehmen der Vinzenz Gruppe', 'geoPoint': {'lat': 48.20849, 'lon': 16.37208}}, {'zip': '1160', 'city': 'Vienna', 'status': 'RECRUITING', 'country': 'Austria', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Klinik Ottakring, Wilhelminenspital der Stadt Wien', 'geoPoint': {'lat': 48.20849, 'lon': 16.37208}}, {'zip': '4600', 'city': 'Wels', 'status': 'NOT_YET_RECRUITING', 'country': 'Austria', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Kepler Universitätsklinikum', 'geoPoint': {'lat': 48.16667, 'lon': 14.03333}}, {'zip': '2700', 'city': 'Wiener Neustadt', 'status': 'NOT_YET_RECRUITING', 'country': 'Austria', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Landesklinikum Wiener Neustadt', 'geoPoint': {'lat': 47.80485, 'lon': 16.23196}}, {'zip': '6511', 'city': 'Zams', 'status': 'RECRUITING', 'country': 'Austria', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Krankenhaus St. Vinzenz in Zams', 'geoPoint': {'lat': 47.15844, 'lon': 10.5897}}, {'zip': '9300', 'city': 'Aalst', 'status': 'RECRUITING', 'country': 'Belgium', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'OLV Hospital Aalst', 'geoPoint': {'lat': 50.93604, 'lon': 4.0355}}, {'zip': '1090', 'city': 'Bonheiden', 'status': 'RECRUITING', 'country': 'Belgium', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Imelda vzw', 'geoPoint': {'lat': 51.02261, 'lon': 4.54714}}, {'zip': '1070', 'city': 'Brussels', 'status': 'RECRUITING', 'country': 'Belgium', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'HUB institut Jules Bordet', 'geoPoint': {'lat': 50.85045, 'lon': 4.34878}}, {'zip': '6000', 'city': 'Charleroi', 'status': 'RECRUITING', 'country': 'Belgium', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Grand hôpital de Charleroi', 'geoPoint': {'lat': 50.41136, 'lon': 4.44448}}, {'zip': '2650', 'city': 'Edegem', 'status': 'RECRUITING', 'country': 'Belgium', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Antwerp University Hospital', 'geoPoint': {'lat': 51.15662, 'lon': 4.44504}}, {'zip': '9000', 'city': 'Ghent', 'status': 'RECRUITING', 'country': 'Belgium', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'UZ Gent', 'geoPoint': {'lat': 51.05, 'lon': 3.71667}}, {'zip': '7100', 'city': 'Haine-Saint-Paul', 'status': 'RECRUITING', 'country': 'Belgium', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'CHU Helora Hospital de La Louvière - Site Jolimont', 'geoPoint': {'lat': 50.45544, 'lon': 4.1885}}, {'zip': '3500', 'city': 'Hasselt', 'status': 'RECRUITING', 'country': 'Belgium', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'JESSA Hasselt', 'geoPoint': {'lat': 50.93106, 'lon': 5.33781}}, {'zip': '3000', 'city': 'Jette', 'status': 'RECRUITING', 'country': 'Belgium', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'UZ Brussel', 'geoPoint': {'lat': 50.87309, 'lon': 4.33419}}, {'zip': '3000', 'city': 'Leuven', 'status': 'RECRUITING', 'country': 'Belgium', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'UZ Leuven', 'geoPoint': {'lat': 50.87959, 'lon': 4.70093}}, {'zip': '8800', 'city': 'Roeselare', 'status': 'WITHDRAWN', 'country': 'Belgium', 'facility': 'AZ Delta', 'geoPoint': {'lat': 50.94653, 'lon': 3.12269}}, {'zip': '63739', 'city': 'Aschaffenburg', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'MVZ am Klinikum Aschaffenburg', 'geoPoint': {'lat': 49.97704, 'lon': 9.15214}}, {'zip': '86156', 'city': 'Augsburg', 'status': 'WITHDRAWN', 'country': 'Germany', 'facility': 'Universitätsklinikum Augsburg', 'geoPoint': {'lat': 48.37154, 'lon': 10.89851}}, {'zip': '10249', 'city': 'Berlin', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Vivantes Klinikum im Friedrichshain', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '12203', 'city': 'Berlin', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Charite Campus Benjamin Franklin', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '09116', 'city': 'Chemnitz', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Klinikum Chemnitz gGmbH', 'geoPoint': {'lat': 50.8357, 'lon': 12.92922}}, {'zip': '50677', 'city': 'Cologne', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'MV-Zentrum für Hämatologie & Onkologie', 'geoPoint': {'lat': 50.93333, 'lon': 6.95}}, {'zip': '40225', 'city': 'Düsseldorf', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Universitätsklinikum Düsseldorf', 'geoPoint': {'lat': 51.22172, 'lon': 6.77616}}, {'zip': '45147', 'city': 'Essen', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'University Hospital Essen', 'geoPoint': {'lat': 51.45657, 'lon': 7.01228}}, {'zip': '35392', 'city': 'Giessen', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Universitaetsklinikum Giessen und Marburg, Standort Giessen', 'geoPoint': {'lat': 50.58727, 'lon': 8.67554}}, {'zip': '73035', 'city': 'Göppingen', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Alb Fils Kliniken GmbH', 'geoPoint': {'lat': 48.70354, 'lon': 9.65209}}, {'zip': '20249', 'city': 'Hamburg', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Hämatologisch-Onkologische Praxis Eppendorf (HOPE)', 'geoPoint': {'lat': 53.55073, 'lon': 9.99302}}, {'zip': '30161', 'city': 'Hanover', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Studienzentrum am Raschplatz GbR', 'geoPoint': {'lat': 52.37052, 'lon': 9.73322}}, {'zip': '30459', 'city': 'Hanover', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'KRH Klinikum Siloah', 'geoPoint': {'lat': 52.37052, 'lon': 9.73322}}, {'zip': '30625', 'city': 'Hanover', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Gemeinschaftspraxis Dr. Haytham Kamal / Dr. David C. Dorn', 'geoPoint': {'lat': 52.37052, 'lon': 9.73322}}, {'zip': '76133', 'city': 'Karlsruhe', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Städtisches Klinikum Karlsruhe', 'geoPoint': {'lat': 49.00937, 'lon': 8.40444}}, {'zip': '04103', 'city': 'Leipzig', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'ÜBAG MVZ Mitte / MVZ Delitzsch GmbH', 'geoPoint': {'lat': 51.33962, 'lon': 12.37129}}, {'zip': '39104', 'city': 'Magdeburg', 'status': 'WITHDRAWN', 'country': 'Germany', 'facility': 'Praxis Hämatologie und Onkologie Magdeburg', 'geoPoint': {'lat': 52.13129, 'lon': 11.63189}}, {'zip': '39120', 'city': 'Magdeburg', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Universitätsklinik für Gastroenterologie, Hepatologie und Infektiologie', 'geoPoint': {'lat': 52.13129, 'lon': 11.63189}}, {'zip': '81675', 'city': 'München', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Klinikum rechts der Isar der Technischen Universität München', 'geoPoint': {'lat': 51.60698, 'lon': 13.31243}}, {'zip': '77654', 'city': 'Offenburg', 'status': 'WITHDRAWN', 'country': 'Germany', 'facility': 'Pi.Tri-Studien GmbH', 'geoPoint': {'lat': 48.47377, 'lon': 7.94495}}, {'zip': '72764', 'city': 'Reutlingen', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Klinikum am Steinenberg Reutlingen', 'geoPoint': {'lat': 48.49144, 'lon': 9.20427}}, {'zip': '31737', 'city': 'Rinteln', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Nädler GmbH', 'geoPoint': {'lat': 52.18604, 'lon': 9.07917}}, {'zip': '66113', 'city': 'Saarbrücken', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'CaritasKlinikum Saarbrücken', 'geoPoint': {'lat': 49.23262, 'lon': 7.00982}}, {'zip': '53840', 'city': 'Troisdorf', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Praxis Onkologie Rheinsieg', 'geoPoint': {'lat': 50.80901, 'lon': 7.14968}}, {'zip': '97080', 'city': 'Würzburg', 'status': 'WITHDRAWN', 'country': 'Germany', 'facility': 'Universitätsklinikum Würzburg (UKW)', 'geoPoint': {'lat': 49.79391, 'lon': 9.95121}}, {'zip': '60126', 'city': 'Ancona Torrette', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'AOU delle Marche'}, {'zip': '14100', 'city': 'Asti', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'ASL AT - Presidio Ospedaliero "Cardinal Massaia"', 'geoPoint': {'lat': 44.90162, 'lon': 8.20751}}, {'zip': '70013', 'city': 'Castellana Grotte', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'IRCCS "S. De Bellis"', 'geoPoint': {'lat': 40.88643, 'lon': 17.16549}}, {'zip': '95122', 'city': 'Catania', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'ARNAS Garibaldi - PO Nesima', 'geoPoint': {'lat': 37.49223, 'lon': 15.07041}}, {'zip': '50134', 'city': 'Florence', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'AOU Careggi', 'geoPoint': {'lat': 43.77925, 'lon': 11.24626}}, {'zip': '16132', 'city': 'Genova', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'IRCCS AOU San Martino', 'geoPoint': {'lat': 45.21604, 'lon': 11.87211}}, {'zip': '20132', 'city': 'Milan', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'IRCCS Ospedale San Raffaele', 'geoPoint': {'lat': 42.78235, 'lon': 12.59836}}, {'zip': '20133', 'city': 'Milan', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Fondazione IRCCS Istituto Nazionale dei Tumori', 'geoPoint': {'lat': 42.78235, 'lon': 12.59836}}, {'zip': '41124', 'city': 'Modena', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Azienda Ospedaliero-Universitaria di Modena', 'geoPoint': {'lat': 44.64783, 'lon': 10.92539}}, {'zip': '09042', 'city': 'Monserrato', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'A.O.U. Cagliari - Policlinico Universitario Duilio Casula', 'geoPoint': {'lat': 39.25642, 'lon': 9.1444}}, {'zip': '80131', 'city': 'Napoli', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Istituto Nazionale Tumori IRCCS Fondazione G. Pascale', 'geoPoint': {'lat': 40.87618, 'lon': 14.5195}}, {'zip': '80131', 'city': 'Napoli', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Università degli studi di Napoli Federico II', 'geoPoint': {'lat': 40.87618, 'lon': 14.5195}}, {'zip': '80131', 'city': 'Napoli', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': "Università della Campania 'Luigi Vanvitelli'", 'geoPoint': {'lat': 40.87618, 'lon': 14.5195}}, {'zip': '56126', 'city': 'Pisa', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'AOU Pisana - Stabilimento Santa Chiara', 'geoPoint': {'lat': 43.70853, 'lon': 10.4036}}, {'zip': '13875', 'city': 'Ponderano', 'status': 'RECRUITING', 'country': 'Italy', 'facility': 'Azienda Sanitaria Locale di Biella - Ospedale degli Infermi', 'geoPoint': {'lat': 45.53846, 'lon': 8.05592}}, {'zip': '48121', 'city': 'Ravenna', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'AUSL della Romagna - Ospedale "S. Maria delle Croci" di Ravenna', 'geoPoint': {'lat': 44.41344, 'lon': 12.20121}}, {'zip': '00128', 'city': 'Roma', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Policlinico Universitario Campus Bio-Medico', 'geoPoint': {'lat': 44.99364, 'lon': 11.10642}}, {'zip': '00182', 'city': 'Roma', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'AO San Camillo Forlanini', 'geoPoint': {'lat': 44.99364, 'lon': 11.10642}}, {'zip': '00184', 'city': 'Roma', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'AO San Giovanni Addolorata', 'geoPoint': {'lat': 44.99364, 'lon': 11.10642}}, {'zip': '71013', 'city': 'San Giovanni Rotondo', 'status': 'RECRUITING', 'country': 'Italy', 'facility': 'IRCCS Ospedale Casa Sollievo della Sofferenza', 'geoPoint': {'lat': 41.70643, 'lon': 15.7277}}, {'zip': '73039', 'city': 'Tricase', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'AO "Cardinale Giovanni Panico"', 'geoPoint': {'lat': 39.93018, 'lon': 18.35421}}, {'zip': '33100', 'city': 'Udine', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'ASU FC - Ospedale "Santa Maria della Misericordia"', 'geoPoint': {'lat': 46.0693, 'lon': 13.23715}}, {'zip': '36100', 'city': 'Vicenza', 'status': 'RECRUITING', 'country': 'Italy', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Azienda ULSS 8 Berica - Ospedale San Bortolo', 'geoPoint': {'lat': 45.54672, 'lon': 11.5475}}, {'zip': '2805-267', 'city': 'Almada', 'status': 'NOT_YET_RECRUITING', 'country': 'Portugal', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'ULS Almada-Seixal', 'geoPoint': {'lat': 38.67902, 'lon': -9.1569}}, {'zip': '4710-243', 'city': 'Braga', 'status': 'NOT_YET_RECRUITING', 'country': 'Portugal', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'USL Braga', 'geoPoint': {'lat': 41.5514, 'lon': -8.42311}}, {'zip': '3004-561', 'city': 'Coimbra', 'status': 'NOT_YET_RECRUITING', 'country': 'Portugal', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'ULS Coimbra', 'geoPoint': {'lat': 40.20686, 'lon': -8.41996}}, {'zip': '1099-023', 'city': 'Lisbon', 'status': 'NOT_YET_RECRUITING', 'country': 'Portugal', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'IPO Lisboa', 'geoPoint': {'lat': 38.72509, 'lon': -9.1498}}, {'zip': '1400-038', 'city': 'Lisbon', 'status': 'NOT_YET_RECRUITING', 'country': 'Portugal', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'CC Champalimaud', 'geoPoint': {'lat': 38.72509, 'lon': -9.1498}}, {'zip': '1500-650', 'city': 'Lisbon', 'status': 'NOT_YET_RECRUITING', 'country': 'Portugal', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Hospital da Luz', 'geoPoint': {'lat': 38.72509, 'lon': -9.1498}}, {'zip': '4050-342', 'city': 'Porto', 'status': 'NOT_YET_RECRUITING', 'country': 'Portugal', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'ULS Santo António', 'geoPoint': {'lat': 41.1485, 'lon': -8.61097}}, {'zip': '5000-508', 'city': 'Vila Real', 'status': 'NOT_YET_RECRUITING', 'country': 'Portugal', 'contacts': [{'name': 'Principal Investigator', 'role': 'CONTACT'}], 'facility': 'Vila Real', 'geoPoint': {'lat': 41.3001, 'lon': -7.7432}}], 'centralContacts': [{'name': 'Contact for Clinical Trial Information', 'role': 'CONTACT', 'email': 'CTRinfo@dsi.com', 'phone': '908-992-6400'}], 'overallOfficials': [{'name': 'Global Team Leader', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}